Healthcare Triangle is trading 5.7% down at $0.46 in pre-market amid uncertainty over Nasdaq’s delisting appeal. - Nasdaq’s determination followed a fall below its $1.00 minimum bid-price requirement; the appeal deadline was October 8. The company said it intended to request a hearing; a timely appeal would stay suspension while the panel considers its case. - No new October 12 announcement confirming the appeal outcome surfaced in the search. The stock closed at $0.48 on October 9 and $0.51 on October 8, while broader-market futures were modestly higher.